Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
Stoke Therapeutics, Inc.
IPO Date: June 17, 2019
Sector: Healthcare
Industry: Biotech
Market Cap: $1.9B
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.65 | 3.30%
Avg Daily Range (30 D): $0.77 | 2.79%
Avg Daily Range (90 D): $0.50 | 2.53%
Institutional Daily Volume
Avg Daily Volume: .31M
Avg Daily Volume (30 D): 1.06M
Avg Daily Volume (90 D): .8M
Trade Size
Avg Trade Size (Sh.): 76
Avg Trade Size (Sh.) (30 D): 69
Avg Trade Size (Sh.) (90 D): 66
Institutional Trades
Total Inst.Trades: 1,246
Avg Inst. Trade: $1.92M
Avg Inst. Trade (30 D): $3.09M
Avg Inst. Trade (90 D): $2.44M
Avg Inst. Trade Volume: .12M
Avg Inst. Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $1.6M
Avg Closing Trade (30 D): $4.2M
Avg Closing Trade (90 D): $2.52M
Avg Closing Volume: 94.23K
   
News
Jun 28, 2024 @ 4:01 PM
A Closer Look at 5 Analyst Recommendations For Sto...
Source: Benzinga Insights
May 6, 2024 @ 3:01 PM
Analyst Expectations For Stoke Therapeutics's Futu...
Source: Benzinga Insights
May 6, 2024 @ 12:05 PM
Stoke Therapeutics, Inc. (STOK) Reports Q1 Loss, T...
Source: Zacks Equity Research
Apr 29, 2024 @ 2:00 PM
Earnings Preview: Axsome Therapeutics (AXSM) Q1 Ea...
Source: Zacks Equity Research
Apr 25, 2024 @ 2:01 PM
Earnings Preview: Stoke Therapeutics, Inc. (STOK) ...
Source: Zacks Equity Research
Financials
  TTM Q2 2025 Q1 2025
Basic EPS $.91 $-.4 $1.95
Diluted EPS $.86 $-.4 $1.9
Revenue $ 199.89M $ 13.82M $ 158.57M
Gross Profit $ $ $
Net Income / Loss $ 52.48M $ -23.48M $ 112.88M
Operating Income / Loss $ 40.28M $ -27.3M $ 111.24M
Cost of Revenue $ $ $
Net Cash Flow $ -91.78M $ -173.35M $ 146.83M
PE Ratio 36.35    
Splits
Jun 06, 2019:   10:99